春立医疗(01858)股价涨超3%,报9.81港元。公司2025年第一季度报告显示,营业收入达2.3亿元,同比增长3.6%;净利润为5807.11万元,同比增长5.2%。华创证券指出,集采影响逐渐出清,公司有望重回增长轨道。受益于长期较高的研发投入,公司在2025年前四个月中,多个新产品如正畸支抗钉、电池供电骨组织手术设备等获得批准,进一步完善了口腔产品线并增强了骨科产品的竞争力。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.